ArticlePharmacoepidemiology and drug safety2026

Early Identification of Cardiovascular Adverse Events Associated With Rofecoxib Using Real-World Data From the UK: A Nested Case-Control and Case-Crossover Study.

Donya Moslemzadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.